Glioma cell proliferation is inhibited by miR-342-3p, miR-377 / E2F1 signaling pathway

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are key regulators in tumor development, influencing glioma progression by targeting genes.
• The precise mechanisms of miRNA signaling pathways in glioma remain incompletely understood.

Purpose of the Study:

• To investigate the role of miR-342-3p and miR-377 in glioma cell proliferation and cell cycle regulation.
• To identify the downstream targets of miR-342-3p and miR-377 in glioma.

Main Methods:

• Cell proliferation assays were performed on glioma cell lines.
• Cell cycle analysis was conducted using flow cytometry.
• Quantitative real-time PCR and Western blotting were used to assess gene and protein expression.
• Luciferase reporter assays were employed to validate miRNA-target interactions.

Main Results:

• miR-342-3p and miR-377 significantly inhibited glioma cell proliferation and induced G1 phase cell cycle arrest.
• Inhibition of miR-342-3p and miR-377 led to increased cell proliferation.
• E2F1 was identified as a direct target of miR-342-3p and miR-377, with both miRNAs repressing E2F1 expression at mRNA and protein levels.
• Downregulation of E2F1 mimicked the effects of miR-342-3p and miR-377, inhibiting proliferation and arresting the cell cycle.
• Overexpression of E2F1 abrogated the anti-proliferative effects of miR-342-3p and miR-377.

Conclusions:

• The miR-342-3p/miR-377/E2F1 axis plays a crucial role in regulating glioma cell proliferation and cell cycle progression.
• This axis represents a potential therapeutic target for glioma treatment.